Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.14 by 57.14 percent. This is a 15.38 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $182.200 million which beat the analyst consensus estimate of $170.000 million by 7.18 percent. This is a 8.78 percent increase over sales of $167.500 million the same period last year.